Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SKI-178 | 1259484-97-3 | 99.3% | 10 MG
SDP

Catalog No. 5000339425
Encompass_Preferred

SKI-178 is a potent inhibitor of both sphingosine kinase-1 (SphK1) and SphK2. It exhibits cytotoxicity at IC50 concentrations ranging from 0.1 to 1.8 μM in various cancer cell lines, including those resistant to multiple agents. This compound has been shown to induce apoptosis in human acute myeloid leukemia cell lines through a CDK1-dependent mechanism.

  • Potent sphingosine kinase-1 and SphK2 inhibitor
  • Exhibits cytotoxicity in various cancer cell lines
  • Induces apoptosis in a CDK1-dependent manner
  • Inhibits leukemic progression in an MLL-AF9 mouse model
  • Suitable for in vitro and in vivo studies

Catalog No. 50-003-39425 Supplier Medchemexpress LLC Supplier No. HY1289210MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SKI-178 is a potent inhibitor of both sphingosine kinase-1 (SphK1) and SphK2. It exhibits cytotoxicity at IC50 concentrations ranging from 0.1 to 1.8 μM in various cancer cell lines, including those resistant to multiple agents. This compound has been shown to induce apoptosis in human acute myeloid leukemia cell lines through a CDK1-dependent mechanism.

  • Potent sphingosine kinase-1 and SphK2 inhibitor
  • Exhibits cytotoxicity in various cancer cell lines
  • Induces apoptosis in a CDK1-dependent manner
  • Inhibits leukemic progression in an MLL-AF9 mouse model
  • Suitable for in vitro and in vivo studies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.